Drug pricing reform in the Inflation Reduction Act (IRA) is expected to have a considerable impact on the pharmaceutical industry. What do stakeholders need to know, and how can they prepare? In this webinar, a team of industry experts talk about what the IRA means for pharma.   

During this session, we discuss:

• Key provisions that will affect pharma manufacturers
• Potential implications for industry stakeholders
• How the industry can prepare for the IRA's impact